Bolt Biotherapeutics, Inc.
USD3.90
-0.37 (-8.66%)
CEO
William Quinn
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.41
Prev. Close
$4.28
Day Low
$3.90
Day High
$4.41
52W Low
$3.75
52W High
$7.20
Market Cap
$0.01B
Volume
0.08M
| 5,000 |
| $4.43 |
| 11 Jun 2026 | Dupont Jakob | director | A-Award | Acquired | 5,000 | $4.43 |
| 11 Jun 2026 | O'CALLAGHAN BRIAN | director | A-Award | Acquired | 5,000 | $4.43 |
| 11 Jun 2026 | ONETTO NICOLE | director | A-Award | Acquired | 5,000 | $4.43 |
| 4 Feb 2026 | Quinn William P. | director, officer: President, CEO and CFO | P-Purchase | Acquired | 125 | $4.61 |
| 4 Feb 2026 | Quinn William P. | director, officer: President, CEO and CFO | A-Award | Acquired | 20,000 | $6.71 |
| 4 Feb 2026 | Yonehiro Grant | Chief Operating Officer | A-Award | Acquired | 10,000 | $6.71 |
| 4 Feb 2026 | Nemec Sarah | Senior VP, Finance and PAO | P-Purchase | Acquired | 125 | $4.61 |
| 4 Feb 2026 | Nemec Sarah | Senior VP, Finance and PAO | A-Award | Acquired | 8,000 | $6.71 |